talazoparib
Talazoparib is a drug used to treat Breast Cancer, Advanced Solid Tumors, Breast Neoplasms, and other conditions. Talazoparib is being actively studied in 52 studies and prior, has been studied in 13.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Pfizer | The University of Texas MD Anderson Cancer Center | Aditya Bardia |
National Cancer Institute (NCI) | M D Anderson Cancer Center | Atish Choudhury |
Dana-Farber Cancer Institute | Washington University School of Medicine | Bryan Schneider, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
- Breast Cancer
- Talazoparib
- Avelumab
- Washington, District of Columbia
- +2 more
2022-03-14
Mar 14, 2022R
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Gemtuzumab Ozogamicin
- +4 more
- Buffalo, New YorkRoswell Park Cancer Institute
2022-02-25
Feb 25, 2022P
Completed
- Neoplasms
- talazoparib
- Changchun, Jilin, China
- +1 more
2022-01-12
Jan 12, 2022C
Recruiting
- Metastatic or Unresectable Melanoma
- Nivolumab
- Talazoparib
- Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-03-22
Mar 22, 2022S
Not yet recruiting
- Acute Myeloid Leukemia
- Talazoparib
- +2 more
- Stanford, CaliforniaStanford University
2021-10-28
Oct 28, 2021M
Active, not recruiting
- Breast Adenocarcinoma
- +4 more
- Laboratory Biomarker Analysis
- Talazoparib
- Houston, TexasM D Anderson Cancer Center
2022-02-09
Feb 9, 2022M
Recruiting
- Breast Cancer
- Talazoparib
- Sacituzumab Govitecan
- Boston, MassachusettsMassachusetts General Hospital Cancer Center
2021-10-25
Oct 25, 2021D
Recruiting
- Leukemia
- Talazoparib
- Boston, Massachusetts
- +1 more
2021-08-23
Aug 23, 2021U
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- Belinostat
- Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
2022-03-31
Mar 31, 2022T
Recruiting
- Recurrent Glioma
- +4 more
- Talazoparib
- Hong Kong, Hong KongDepartment of Clinical Oncology
2021-08-19
Aug 19, 2021D
Recruiting
- Metastatic Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Talazoparib
- Tazemetostat
- Boston, Massachusetts
- +1 more
2021-07-12
Jul 12, 2021U
Recruiting
- HRD 100 Gene Expression High
- Triple Negative Breast Cancer
- Talazoparib
- Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
2022-03-15
Mar 15, 2022U
Active, not recruiting
- Acute Myeloid Leukemia
- Decitabine
- talazoparib
- Baltimore, MarylandUniversity of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021N
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Talazoparib
- Temozolomide
- Bethesda, MarylandNational Cancer Institute LAO
2022-04-07
Apr 7, 2022M
Active, not recruiting
- Advanced Malignant Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-21
Feb 21, 2022M
Recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Talazoparib
- Badalona, Spain
- +8 more
2022-03-28
Mar 28, 2022H
Not yet recruiting
- Ovarian Cancer
- +2 more
- ZEN003694
- Talazoparib
- Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
2022-03-14
Mar 14, 2022K
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- ASTX727
- Indianapolis, Indiana
- +1 more
2021-09-28
Sep 28, 2021K
Recruiting
- TNBC - Triple-Negative Breast Cancer
- Gedatolisib
- Talazoparib
- Chicago, Illinois
- +4 more
2022-01-18
Jan 18, 2022N
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
- Singapore, SingaporeNational University Hospital
2021-08-31
Aug 31, 2021N
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
- New Brunswick, New Jersey
- +2 more
2022-01-25
Jan 25, 2022M
Not yet recruiting
- Prostate Cancer Metastatic
- Telaglenastat
- Talazoparib
- Boston, MassachusettsMassachusetts General Hospital
2021-03-27
Mar 27, 2021Z
Active, not recruiting
- Triple Negative Breast Cancer
- ZEN003694
- Talazoparib
- Gilbert, Arizona
- +9 more
2022-02-07
Feb 7, 2022M
Recruiting
- Metastatic Renal Cell Carcinoma
- +2 more
- Talazoparib
- Avelumab
- Basking Ridge, New Jersey
- +6 more
2021-12-21
Dec 21, 2021S
Completed
- Childhood Solid Tumors
- Talazoparib
- +4 more
- Memphis, TennesseeSt. Jude Children's Research Hospital
2021-02-08
Feb 8, 2021